# FDA Inspection 1084838 - Maxim Biomedical Inc. - February 07, 2019

Source: https://www.keypedia.com/records/fda_inspections/maxim-biomedical-inc/020d2d68-bec4-443d-ba2c-dcfb0969f7e7
Source feed: FDA_Inspections

> FDA Inspection 1084838 for Maxim Biomedical Inc. on February 07, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084838
- Company Name: Maxim Biomedical Inc.
- Inspection Date: 2019-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1270828 - 2025-05-07](https://www.keypedia.com/records/fda_inspections/maxim-biomedical-inc/867a7646-dd4e-4eff-ad87-defd6c12faad)
- [FDA Inspection 1270828 - 2025-05-07](https://www.keypedia.com/records/fda_inspections/maxim-biomedical-inc/7316f1df-ac66-4466-b3c3-dee062805bc0)
- [FDA Inspection 1222136 - 2023-11-02](https://www.keypedia.com/records/fda_inspections/maxim-biomedical-inc/3e7593d4-2a58-4579-98cc-372dae4f255c)
- [FDA Inspection 1222136 - 2023-11-02](https://www.keypedia.com/records/fda_inspections/maxim-biomedical-inc/ca83f3fd-3aea-4f81-aaef-94b69fa5d681)
- [FDA Inspection 1068675 - 2018-09-18](https://www.keypedia.com/records/fda_inspections/maxim-biomedical-inc/05e49017-9077-4d36-8b94-5d2a10aac316)

Company: https://www.keypedia.com/companies/maxim-biomedical-inc/443168dc-1a76-40a1-9f04-e2befa5aced7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d